JPRN-UMIN000045917已完成未知
Verification of efficacy and long-term intake safety of test food intake for liver function in healthy adults - Verification of efficacy and long-term intake safety of test food intake for liver function in healthy adults
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 65years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Subject who has been diagnosed with serious liver disease (viral hepatitis, drug-induced liver injury, liver cirrhosis, etc.) by a doctor, or those who have a medical history or are suspected (hepatitis virus test positive, etc.) 2.Subject who is currently undergoing medication or outpatient treatment due to some serious illness. 3.Subject who is under exercise therapy or dietetic therapy. 4.Subject who may develop allergies due to test foods. 5.Subject with current or history of drug or alcohol dependence. 6.Alcohol polydipsia. 7.Subject who is out of the hospital due to mental disorders (depression, etc.) or sleep disorders(Insomnia, sleep apnea syndrome, etc.), or who has a history of mental illness in the past. 8.Subject with irregular life rhythms due to night shifts or shift work. 9.Subject who has extremely irregular lifestyle habits such as eating and sleeping. 10.Subject who has an extremely unbalanced diet. 11.Subject with serious current or history of brain disease, malignant tumor, immune disease, diabetes, renal disease, heart disease, thyroid disease, adrenal disease, and other metabolic diseases. 12.Subject who uses or cannot refrain from using health foods, supplements, medicines, quasi-drugs, Chinese medicine, etc. that contain ingredients that affect liver function (eg, ornithine, sulforaphane, turmeric, etc.)
研究者
相似试验
已完成
Unknown
A study to confirm the safety of long-term intake of bifidobacteria : a placebo-controlled, randomized, double-blind study.JPRN-UMIN000049596KSO Corporation30
已完成
Unknown
Efficacy trial and long-term safety confirmation test- Efficacy and long-term safety of the test food TK61406 ingested as a single dose, in a double-blind, parallel-group comparison to placebo.A range of individuals from healthy to borderline conditions- Persons with tendency for constipation or diarrhea- Persons classified as normal to 1 degree of obesity- Persons classified with normal to 1 degree of average blood pressureJPRN-jRCT1091220210Tokai Pickling Co.,Ltd. Yasufumi Ohba, Masataka Fujita, Mitsuru Satsukawa, Tetsuhiro Kawamoto, Mika Komura, Shoko Nishio, Tetsuya Iyoda,Hiroshi Ono30
尚未招募
不适用
A study to evaluate the safety of long-term intake of plant extract materialsHealthy volunteersJPRN-UMIN000047688Soiken Inc.40
已完成
不适用
A study to evaluate the safety of long-term intake of test food in healthy adult subjectsHealty volunteersJPRN-UMIN000048008Pharma Foods International Co.,Ltd.24
已完成
4 期
Evaluation of Long-term efficacy, safety and predictors of Adalimumab in Crohn's disease: Japanese multicenter cohort study (ADJUST study)Crohn's diseaseJPRN-UMIN000014708IBD Center, Sapporo Kosei General Hospital500
